LAVAL, QC, Oct. 24, 2013 /CNW Telbec/ - Wishing to further reinforce its
status as a Canadian leader in skin care, Valeant Canada LP has today
announced that its Canadian cosmeceutical division will henceforth be
called Valeant Groupe Cosméderme Inc.
This change reflects the organization's determination to bank on the
synergies derived from its recent acquisition of Obagi Medical
Products, and to build on the Laboratoire Dr Renaud heritage of fifty-plus years of innovations that have been driving the
company ever since its inception.
"The name is new, but the tradition of excellence that made our
reputation and drives our success goes on. Laboratoire Dr Renaud has reached the pinnacle in the beauty sector and we will devote our
energy to remain the standard-bearers in our rapidly-growing industry.
By integrating Obagi into our organization, we are cementing our
presence, redeploying our activities and seizing the myriad
opportunities before us. We will continue to offer top-performance
products, which is exactly what our customers have come to expect from
us," declared Valeant Groupe Cosméderme General Manager Carl St-Pierre.
Recall that Laboratoire Dr Renaud joined the Valeant family in 2009. Since then, the brand has become a
business division at the heart of the company's diversification and
About Valeant Canada
Valeant Canada is a subsidiary of Valeant Pharmaceuticals International,
Inc., a multinational specialty pharmaceutical company that develops,
manufactures and markets a broad range of pharmaceutical products
primarily in the areas of dermatology, eye health, neurology, and
branded generics. More information about Valeant Canada can be found
SOURCE: Valeant Canada
For further information:
VALEANT CANADA LP